Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.

Citation: Huang A, Moretto A, Janz K, Lowe M, Bedard PW, Tam S, Di L, Clerin V, Sushkova N, Tchernychev B, Tsao DH, Keith JC, Shaw GD, Schaub RG, Wang Q, Kaila N.: Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury. J Med Chem, Volume 53 (16), 2010
Authors: Bedard PW, Clerin V, Di L, Huang A, Janz K, Kaila N., Keith JC, Lowe M, Moretto A, Schaub RG, Shaw GD, Sushkova N, Tam S, Tchernychev B, Tsao DH, Wang Q
Journal: J Med Chem
Year: 2010
DOI: 10.1021/jm9013696
PubMed: 20718494
Machine-readable: REST API RDF

Publication